Back to search
FDAFDA · Food and drugs·Recall number D-1205-2018

MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD NDC 59746-001-03

Published September 26, 2018 · Recall initiated: August 27, 2018

Summary

FDA records drug Class III recall D-1205-2018, published September 26, 2018 and initiated August 27, 2018. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 89,722 blister pack; Lot: Lot # 17P0078, exp. date 12/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
Product was distributed throughout the United States.
Lot
Lot # 17P0078, exp. date 12/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD NDC 59746-001-03 recalled?

Yes. FDA published recall D-1205-2018 on September 26, 2018. Reported hazard: Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.

What should I do if I have this product?

Voluntary: Firm initiated · Letter